BillionToOne
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
About BillionToOne
BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries. BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.
Company Facts
- Headquarters
- Menlo Park
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00501_01000
- Funding Stage
- ipo
- Total Funding
- $425,900,000
- Last Funding Type
- series_d
- Last Funding Date
- 2024-06-21
- Website
- billiontoone.com
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Medical
Social Links
Canonical: https://fsome.com/organization/billiontoone-3155 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.